Ocugen Inc (OCGN)
1.52
+0.09
(+6.29%)
USD |
NASDAQ |
Jun 28, 16:00
1.50
-0.02
(-1.32%)
After-Hours: 07:35
Ocugen SG&A Expense (TTM): 30.20M for March 31, 2024
SG&A Expense (TTM) Chart
Historical SG&A Expense (TTM) Data
Date | Value |
---|---|
March 31, 2024 | 30.20M |
December 31, 2023 | 32.11M |
September 30, 2023 | 34.18M |
June 30, 2023 | 32.59M |
March 31, 2023 | 33.59M |
December 31, 2022 | 35.40M |
September 30, 2022 | 35.64M |
June 30, 2022 | 32.66M |
March 31, 2022 | 28.85M |
December 31, 2021 | 22.92M |
September 30, 2021 | 17.66M |
June 30, 2021 | 14.86M |
March 31, 2021 | 9.882M |
December 31, 2020 | 7.974M |
September 30, 2020 | 8.292M |
June 30, 2020 | 7.996M |
March 31, 2020 | 8.832M |
December 31, 2019 | 9.484M |
September 30, 2019 | 9.096M |
June 30, 2019 | 10.11M |
Date | Value |
---|---|
March 31, 2019 | 10.33M |
December 31, 2018 | 10.20M |
September 30, 2018 | 10.73M |
June 30, 2018 | 10.52M |
March 31, 2018 | 9.865M |
December 31, 2017 | 9.384M |
September 30, 2017 | 9.106M |
June 30, 2017 | 8.649M |
March 31, 2017 | 8.644M |
December 31, 2016 | 8.53M |
September 30, 2016 | 8.372M |
June 30, 2016 | 8.795M |
March 31, 2016 | 8.369M |
December 31, 2015 | 8.266M |
September 30, 2015 | 7.757M |
June 30, 2015 | 7.269M |
March 31, 2015 | 6.875M |
December 31, 2014 | 6.565M |
September 30, 2014 | 6.76M |
June 30, 2014 | 5.807M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (TTM) Range, Past 5 Years
7.974M
Minimum
Dec 2020
35.64M
Maximum
Sep 2022
21.70M
Average
22.92M
Median
Dec 2021
SG&A Expense (TTM) Benchmarks
QuidelOrtho Corp | 765.50M |
Checkpoint Therapeutics Inc | 8.844M |
Johnson & Johnson | 21.93B |
Imunon Inc | 8.396M |
iBio Inc | 11.84M |